Thurs. Nov. 3
7:45 AM | 8:00 AM | Introduction and Welcome: A Collective Call to Action |
COMPREHENSIVE APPROACHES TO OBESITY: BLUNTING ITS IMPACT | ||
8:00 AM | 8:30 AM | Exercise: Quick and Effective In-Office Risk Assessment and Personalized “Prescription” Strategies* Edward M. Phillips, MD |
8:30 AM | 9:15 AM | State-of-the-Art Nutritional Approaches to Weight Management: One Size Does Not Fit All* Jody Dushay, MD, MMSc |
9:15 AM | 9:25 AM | Break |
9:25 AM | 10:05 AM | Impacting Diabetes Outcomes with New Techniques for Motivation Interviewing: Here’s How*† Frank J. Domino, MD |
10:05 AM | 10:20 AM | Question and Answer Session |
10:20 AM | 10:35 AM | Break and Guided Meditation✻ |
10:35 AM | 11:20 AM | Pharmacologic Management of Obesity: When. What. How.*† Osama Hamdy, MD, PhD, FACE |
11:20 AM | 11:45 AM | Surgical Treatment of Obesity: Techniques, Outcomes, and a Patient’s Perspective* Daniel B. Jones, MD, MS, FACS Maria Semnack, RN, BSN, CPSN |
11:45 AM | 12:00 PM | Question and Answer Session |
12:00 PM | 12:50 PM | Lunch Break |
12:50 PM | 1:35 PM | Non-Alcoholic Steatohepatitis: Assessing Severity and Optimizing Management Sanjiv Chopra, MD, MACP, FRCP (London) |
1:35 PM | 1:40 PM | Question and Answer Session |
SPECIAL SYMPOSIUM: CARDIOVASCULAR DISEASE AND DIABETES | ||
1:40 PM | 2:25 PM | Optimal Management of Hypertension in People with Diabetes† Melanie P. Hoenig, MD |
2:25 PM | 3:10 PM | Optimal Management of Dyslipidemia in People with Diabetes† Om P. Ganda, MD, MBBS |
3:10 PM | 3:20 PM | Question and Answer Session |
3:20 PM | 3:35 PM | Break & Rejuvenation Exercises✻ |
3:35 PM | 4:00 PM | Common Cardiovascular Tests and Their Optimal Interpretation Michael C. Gavin, MD, MPH, FACC |
4:00 PM | 4:40 PM | Diabetes and Heart Failure: Update on Management† A. Reshad Garan, MD, MS, FACC |
4:40 PM | 4:50 PM | Break |
4:50 PM | 5:35 PM | Management of Acute Coronary Syndromes and Chronic Cardiovascular Disease in Patients with Diabetes† Duane S. Pinto, MD, MPH |
5:35 PM | 5:50 PM | Panel Discussion: Cardiovascular Care in People with Diabetes A. Reshad Garan, MD, MS, FACC Michael C. Gavin, MD, MPH, FACC Duane S. Pinto, MD, MPH |
Fri. Nov. 4
UPDATES ON THE MEDICAL MANAGEMENT OF DIABETES | ||
7:30 AM | 8:20 AM | Beyond Metformin: Navigating and Applying the New Guidelines and Reducing Cardiovascular Risk*† Martin J. Abrahamson, MD, FACP |
8:20 AM | 8:25 AM | Question and Answer Session |
8:25 AM | 9:15 AM | Newer Insulins and How to Use Them: A Comprehensive Primer† Richard S. Beaser, MD |
9:15 AM | 9:20 AM | Question and Answer Session |
9:20 AM | 9:35 AM | Break and Guided Meditation✻ |
9:35 AM | 10:20 AM | The Use of Devices for Diabetes Management*† Anne Peters, MD |
10:20 AM | 10:30 AM | Question and Answer Session |
10:30 AM | 10:40 AM | Break |
SPECIAL WORKSHOP: CHALLENGING CASES IN GLYCEMIC CONTROL | ||
10:40 AM | 11:55 AM | Challenges in Optimizing Glycemic Control: An Interactive Session† Martin J. Abrahamson, MD, FACP Gillian Arathuzik, RD, LDN, CDCES Richard S. Beaser, MD Erin K. Martin, RN, CDCES Alissa R. Segal, PharmD, CDCES, CDTC, FCCP |
11:55 AM | 12:20 PM | Q&A: Medical Management of Diabetes† Faculty |
12:20 PM | 1:10 PM | Lunch Break |
1:10 PM | 1:55 PM | KEYNOTE: Microbiome (the Second Human Genome): What Shapes It and How It Shapes Us Sanjiv Chopra, MD, MACP, FRCP (London) |
1:55 PM | 2:00 PM | Q&A: Medical Management of Diabetes† Faculty |
SPECIAL SITUATIONS | ||
2:00 PM | 2:40 PM | The Challenges of Inpatient Diabetes Management and Transition to Outpatient Care*† Lyle D. Mitzner, MD |
2:40 PM | 2:45 PM | Question and Answer Session |
2:45 PM | 3:00 PM | Break & Rejuvenation Exercises✻ |
3:00 PM | 3:40 PM | Managing Diabetes in the Elderly – Individualizing Care*† Medha N. Munshi, MD |
3:40 PM | 4:20 PM | Care for Pregnant Women and Women Planning to Become Pregnant: Screening, Risk Mitigation, Treatment, Patient Education*† Florence M. Brown, MD |
4:20 PM | 4:30 PM | Question and Answer Session |
4:30 PM | 4:40 PM | Break |
4:40 PM | 5:15 PM | Disparities in Diabetes Care* Samar Hafida, MD |
5:15 PM | 5:25 PM | Question-and-Answer Session |
Sat. Nov. 5
7:30 AM | 8:10 AM | The Top 10 Advances in Diabetes Care† Martin J. Abrahamson, MD, FACP Richard S. Beaser, MD |
8:10 AM | 8:50 AM | The Artificial Pancreas: Ready for Prime Time? Steven J. Russell, MD, PhD |
8:50 AM | 9:10 AM | Break & Guided Meditation✻ |
9:10 AM | 9:50 AM | Future Therapies for Diabetes*† Alan Moses, MD |
9:50 AM | 10:30 AM | Stem Cells David T. Scadden, MD |
10:30 AM | 10:45 AM | Panel Discussion Martin J. Abrahamson, MD, FACP Richard S. Beaser, MD Steven J. Russell, MD, PhD Alan Moses, MD David T. Scadden, MD |
10:45 AM | 11:00 AM | Break |
MICROVASCULAR DISEASE AND DIABETES | ||
11:00 AM | 11:35 AM | Treating Retinopathy: Optimizing the Impact of Recent Advances Deborah K. Schlossman, MD |
11:35 AM | 12:20 PM | Treatment of Renal Disease: Guidance to Blunt the Impact, Slow the Progression† Robert C. Stanton, MD |
12:20 PM | 12:30 PM | Question and Answer Session |
12:30 PM | 1:20 PM | Lunch Break |
THE DIABETIC FOOT | ||
1:20 PM | 2:00 PM | Evaluating and Treating Neuropathies of Diabetes: 2022 Updates Patricia E. Greenstein, MD |
2:00 PM | 2:30 PM | The Foot: Preventing Damage and Treatment Options* John M. Giurini, DPM |
2:30 PM | 2:45 PM | Break & Rejuvenation Exercises✻ |
2:45 PM | 3:15 PM | Peripheral Vascular Disease: Recent Advances in Diagnosis and Management† David R. Campbell, MD, FRCS, FACS |
3:15 PM | 3:30 PM | Question and Answer Session |
SPECIAL SESSION | ||
3:30 PM | 3:45 PM | Indispensable Tips for Incorporating Updates into Clinical Practice Faculty |
3:45 PM | 3:50 PM | Closing Remarks |
Note: Program changes/substitutions may be made without notice.
This agenda was updated on 6/8/2022
*Qualifies for Risk Management Credit
†Qualifies for Pharmacology Credit
✻Optional Wellness Activity